Eloralintide
Product Specifications
UNSPSC Description
Eloralintide (LY 3841136) is an AMYR agonist, which is promising for research of type 2 diabetes and obesity[1].
Target Antigen
Amylin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein
Field of Research
Metabolic Disease
Smiles
OC1=CC=C(C[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@H]2N(CCC2)C([C@H]3N(CCC3)C([C@@H](NC([C@@H](NC([C@H]4N(CCC4)C(CNC([C@@H](NC([C@@H](N(C)C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@](C)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC5=O)CC(N)=O)=O)[C@@H](C)O)=O)C)=O)[C@@H](C)O)=O)CSCSC[C@@H]5NC(CC[C@H](N)C(O)=O)=O)=O)C)=O)[C@@H](C)O)=O)=O)CCCN)=O)CC(C)C)=O)C)=O)CCC(O)=O)=O)CC6=CC=CC=C6)=O)CC(C)C)=O)C(C)C)=O)CCCNC(N)=N)=O)CO)=O)CO)=O)CC(N)=O)=O)CC(N)=O)=O)CC7=CC=CC=C7)=O)=O)=O)CCCCNC(CC[C@H](NC(CC[C@H](NC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)C(O)=O)=O)C(O)=O)=O)=O)CC(C)C)=O)=O)=O)[C@@H](C)O)=O)CCC(O)=O)=O)C(C)C)=O)=O)CO)=O)CC(N)=O)=O)[C@@H](C)O)=O)C(N)=O)C=C1
Molecular Weight
4526.10
References & Citations
[1]A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management With LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes.
Shipping Conditions
Room temperature
Badge
Hot
Clinical Information
Phase 2
CAS Number
2883634-40-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
